Catamount Wealth Management’s Allergan plc AGN Stock Holding History

Catamount Wealth Management’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$19K	Hold	128	–	–	0.01%	116
2018 Q4	$18K	Hold	128	–	–	0.01%	108
2018 Q3	$24K	Hold	128	–	–	0.01%	113
2018 Q2	$24K	Buy	+128	New	+$20.5K	0.01%	107
2017 Q4	–	Sell	-100	Closed	-$20K	–	214
2017 Q3	$20K	Hold	100	–	–	0.01%	119
2017 Q2	$24K	Hold	100	–	–	0.01%	110
2017 Q1	$24K	Hold	100	–	–	0.02%	108
2016 Q4	$21K	Hold	100	–	–	0.02%	98
2016 Q3	$24K	Hold	100	–	–	0.02%	93
2016 Q2	$23K	Buy	+100	New	+$23.1K	0.03%	70
2015 Q3	–	Sell	-24,090	Closed	-$7.31M	–	215
2015 Q2	$7.31M	Buy	24,090 +81	+0.3%	+$24.2K	5.66%	4
2015 Q1	$7.15M	Buy	24,009 +7,444	+45%	+$2.12M	5.88%	3
2014 Q4	$4.26M	Buy	+16,565	New	+$4.14M	4.06%	7

Other funds holding AGN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $6.16B AUM 3.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Catamount Wealth Management's AGN Position: Q1 2019 in Review

Catamount Wealth Management held its Allergan plc (AGN) position steady in Q1 2019 at 128 shares worth $19K. The position accounts for 0.01% of the portfolio, ranked #116.

Catamount Wealth Management first reported a position in AGN in Q4 2014 and has held it in 13 quarters since. The position peaked at $7.31M in Q2 2015. 991 funds tracked by Wall St. Rank hold AGN as of Q1 2019.

Catamount Wealth Management held 128 shares of Allergan plc worth $19K as of Q1 2019.
Catamount Wealth Management left its Allergan plc share count unchanged in Q1 2019.
Allergan plc made up 0.01% of Catamount Wealth Management's portfolio in Q1 2019, its #116 holding.
Catamount Wealth Management first reported a position in Allergan plc in Q4 2014 and has held it in 13 quarters since.
Catamount Wealth Management's Allergan plc position peaked at $7.31M in Q2 2015.
991 funds tracked by Wall St. Rank held Allergan plc as of Q1 2019.

Based on Catamount Wealth Management's 13F filing for Q1 2019, filed 3 May 2019.